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A Change in the NICE Guidelines on Antibiotic Prophylaxis 
In Brief: 
x NICE guidelines on antibiotic prophylaxis have recently changed 
x This change now makes clear that in individual cases, antibiotic 
prophylaxis may be appropriate. 
 
Abstract: 
 
Since 2008, NICE clinical guidelines have stated ǲ
infective endocarditis is not recommended for people undergoing dental 
procedures.ǳ This put UK guidance at odds with guidance in the rest of the world, 
where antibiotic prophylaxis is recommended for patients at high-risk of 
infective endocarditis undergoing invasive dental procedures. Many dentists also 
felt this wording prohibited the use of antibiotic prophylaxis, regardless of the 
wishes of the patient or their personal risk of infective endocarditis and made it 
difficult for them to use their clinical judgment to deliver individualized care in 
the best interests of their patients. NICE have now changed this guidance to ǲ
routinely ǳǤ This article examines the 
implications of this small but important change. 
 
  
Introduction: 
This article discusses the implications of this change and provides practical 
advice about when antibiotic prophylaxis may be appropriate 
You would be forgiven for missing it, because it was announced without any 
fanfare, but in July this year NICE made a small but extremely important change 
 ? ?ȋ
 ? ?ȌǡǲProphylaxis against infective endocarditis: 
antimicrobial prophylaxis against infective endocarditis in adults and children 
undergoing ǳ.1 R ?Ǥ ?Ǥ ?ǡǲ
prophylaxis against infective endocarditis is not recommended for people 
undergoing dental proceduresǳ (or other non-dental procedures) has now been ǲ
recommended routinely for people undergoing dental proceduresǳǤ  The 
addition of the word ǲǳis of considerable importance. As pointed out by 
Sir Andrew Dillon (CEO of NICE) in a letter confirming the changeǡǲ
amendment should now make clear that in individual cases, antibiotic ǳǤ 
This is an important and welcome change. Previously, many dentists felt that the 
wording prohibited the use of antibiotic prophylaxis, regardless of the views of 
the patient or their personal risk of infective endocarditis. This change makes it 
clear that in circumstances where the risk of infective endocarditis posed to the 
patient is perceived to be sufficiently high, or when the patient themselves 
expresses a preference for it, antibiotic prophylaxis may be appropriate.  
 
This change follows a review of the NICE guidelines in 2015 which was 
precipitated by a study published in the Lancet2 and concluded that there was 
insufficient evidence to change the guidance.1 Several papers and letters 
published in the BDJ3-5 subsequently made the case that it was inappropriate to 
withhold antibiotic prophylaxis from patients at high-risk of infective 
endocarditis, particularly in light of a recent change in the law concerning 
informed consent.6-8 This change places an onus on clinicians to identify patients 
at increased risk of infective endocarditis, explain the risk and ways in which it 
can be reduced (including antibiotic prophylaxis), and then allow them to decide 
for themselves if they want antibiotic prophylaxis or not.4 In addition, two 
widows whose husbands died from infective endocarditis following hygienist 
visits for dental scaling have been petitioning NICE with the support Chris Philp 
MP for Croydon South. The change in guidance was first mentioned in a letter to 
Chris Philp on 28th June 2016 and appeared shortly afterwards on the official 
NICE web site.1 The change in wording now allows clinicians to comply with the 
new law on consent and another important statement in the NICE guideline, ǲǡ
consultation with the patient and/or their carer or guardian. In doing so, they 
should take account of the recommendations in this guideline and the values and 
preferences of patients, and ǳǤ 
 
As it stands, however, the change poses 3 important unanswered questions for 
dentists faced with implementing the guidelines: 
 
1. How do I determine which patients should receive antibiotic prophylaxis? 
2. Although NICE now acknowledge that antibiotic prophylaxis may be 
appropriate for some patients undergoing dental procedures, it gives no 
advice concerning which dental procedures should be covered. 
3. If antibiotic prophylaxis is appropriate for a particular patient, what 
antibiotic prophylaxis regimen should be given? 
 
In a recent BDJ opinion piece we proposed how dentists should deal with each of 
these issues.4  In the absence of clear guidance from NICE, we reiterate the key 
points here with links to tables and figures from the original article that provide 
more detailed information. Our recommendations are based on the current 
European Society of Cardiology (ESC) guidelines that are applied in the rest of 
Europe and provide a sound clinical basis for dealing with these issues. The ESC 
guidelines have been published in full9 and are also available as a smart phone 
app and a pocket guide at http://www.escardio.org/Guidelines-&-
Education/Clinical-Practice-Guidelines/Infective-Endocarditis-Guidelines-on-
Prevention-Diagnosis-and-Treatment-of. The ESC guidelines recommend 
antibiotic prophylaxis is limited to patients at highest risk of infective 
endocarditis (Link to Table 2 of  BDJ 220(2)51-56) undergoing the highest risk 
dental procedures (Link to Table 3 of  BDJ 220(2)51-56) They emphasise, 
however, that good oral hygiene and regular dental review are even more 
important than antibiotic prophylaxis in reducing the risk of infective 
endocarditis.  
 
How do I decide which patients it is appropriate to consider antibiotic 
prophylaxis for? 
The individuals considered to be at high-risk of infective endocarditis (and 
therefore recommended for antibiotic prophylaxis by the ESC guidelines) are 
shown in Table 2 (Link to Table 2 of  BDJ 220(2)51-56). Those at particularly 
high-risk include those with a previous history of infective endocarditis, those 
with prosthetic or repaired heart valves and those with multiple risk factors e.g. 
a prosthetic heart valve and previous history of endocarditis. Whilst, the ESC 
does not currently recommend antibiotic prophylaxis for those at moderate risk 
(also shown), it does highlight the importance of good oral hygiene and oral care 
with at least annual dental review for these individuals. 
 
In most cases the risk status of a patient will be clear from the medical history 
e.g. previous history of infective endocarditis or prosthetic heart valve 
implantation. For others it may be less clear. Where there is any uncertainty, 
advice should be sougǯȋ
consent) to clarify their risk status and determine the need for antibiotic 
prophylaxis (or not). A record of any such communication should be kept with 
their clinical record. 
 
The new legal framework suggests that the potential consequences of developing 
infective endocarditis need to be discussed with anyone at increased risk. The 
differing views concerning the value of antibiotic prophylaxis and small risk of 
adverse drug reactions related to antibiotics also need to be addressed. We 
previously published a figure that may be helpful when discussing the issue of 
risk with patients (Link to Figure 1 of  BDJ 220(2)51-56).4 Following a clear 
discussion of the facts, it is then for the patient (rather than the clinician) to 
decide if they wish to receive antibiotic prophylaxis. GMC/GDC standards and the 
advice of the medical/dental defence organisations highlight the need for this 
discussion (ǯ decision) to be recorded in the clinical records. 
 ǯ
the level of risk posed to an individual patient. In this situation, the cardiologist 
should provide a letter outlining their advice and the dentist should confirm with 
the patient that this reflects their wishes before acting on the recommendation. 
 
The risk of infective endocarditis developing in an individual with no risk factors 
is so low that it would be reasonable (even in the new legal framework) for the 
clinician to conclude that it is unlikely the patient would attach significance to 
the risk, and therefore not to inform them of these issues. 
 
Which dental procedures are considered high-risk? 
Generally, invasive dental procedures involving the gingival crevice are likely to 
be high-risk procedures and should therefore be considered for antibiotic 
prophylaxis. Table 3 (Link to Table 3 of  BDJ 220(2)51-56), which is based on 
ESC recommendations9 and closely matches the American Heart Association 
(AHA) guidelines10 identifies those dental procedures considered high-risk.  
 
What antibiotic prophylaxis regime should be provided for those 
requesting it? 
The regime recommended by the ESC (Link to Table 4 of  BDJ 220(2)51-56) is 
very similar to that of the AHA10 but differs in two main respects from that 
previously used in the UK. First, the oral dose of Amoxicillin used is 2g rather 
than 3g.  Previously, 3g sachets of Amoxicillin oral powder were used for 
antibiotic prophylaxis in the UK and are still widely available. Moreover, recent 
adverse drug reaction data demonstrate a low level of adverse reactions to the 
3g oral dose11 and it seems reasonable, therefore, to prescribe this formulation. 
The other change is that the pre-NICE UK guidance recommended using 
clindamycin if a patient had received a dose of amoxicillin in the previous month. 
This is not a feature of either the ESC or AHA guidance and, given the higher risk 
of adverse reactions with clindamycin,11 the ESC guidance is likely to be safer.  
That is, amoxicillin antibiotic prophylaxis should be used in those with no history 
of allergy, even if amoxicillin has been used within the previous month. 
 
Both the ESC and AHA guidance currently recommends clindamycin antibiotic 
prophylaxis for those allergic to penicillins. Neither the ESC nor the AHA 
guideline committees have had the opportunity to take account of recent adverse 
reaction data showing a higher rate of adverse reactions with clindamycin 
antibiotic prophylaxis.  Both are likely to do so in the future and may consider 
changing their recommendations. In the meantime, however, whilst not as safe 
as amoxicillin, clindamycin antibiotic prophylaxis is relatively safe and likely to 
be safer than the risk of developing infective endocarditis, particularly for those 
at high-risk. As such, it is probably advisable to adhere to ESC recommendations 
until any change in guidance is announced. 
 
What else should dentists do for patients at increased risk of infective 
endocarditis? 
Dentists should emphasise that good oral hygiene and regular dental review are 
as important as antibiotic prophylaxis (if not more so) in reducing the risk of 
infective endocarditis. The ESC recommend strict dental and cutaneous hygiene 
with dental follow up at least twice a year in high-risk patients and once a year 
for all other (i.e. moderate risk) patients at risk of infective endocarditis. They 
also point out the need to effectively treat foci of infection, adhere to aseptic 
measures during at-risk procedures and explain the risks of body piercing and 
tattooing in those at risk of infective endocarditis. 
 
Mortality and morbidity are very high in patients who develop infective 
endocarditis but are significantly reduced by early diagnosis. Unfortunately, 
early symptoms are often non-specific, making diagnosis difficult and frequently 
delayed. A low threshold of clinical suspicion is therefore vital. Patients at 
increased risk should be advised by their dentists of the signs and symptoms of 
infective endocarditis (Link to Table 5 of  BDJ 220(2)51-56), whether or not they  
choose to have antibiotic prophylaxis, and the need to see their GP quickly 
should they occur, particularly if they develop soon after a high-risk dental 
procedure. Early assessment by the GP (who should be made aware of the ǯȀure) and 
appropriate onward referral to a cardiologist could be life saving. The British 
Heart Foundation produce warning cards that can be given to patients Ȃ 
available at: https://www.bhf.org.uk/publications/heart-conditions/m26a-
endocarditis-card 
 
What other issues are raised by this change? 
This change throws decisions about which patients should receive antibiotic 
prophylaxis back into the hands of cardiologists and dentists while decisions 
about when antibiotic prophylaxis is required (i.e. when a high-risk dental 
procedure is going to be performed) and the prescription of antibiotic 
prophylaxis will reside largely with dentists. No longer can dentists and 
cardiologists ignore this issue because NICE does not recommend antibiotic 
prophylaxis. Moreover, there is now a new generation of dentists whose training 
did not incorporate the issues of infective endocarditis and antibiotic 
prophylaxis. As a consequence, dentists, cardiologists and GPs will need post-
graduate training and CPD courses to update them on the implications of this 
guideline change. Thought will also need to be given to the re-introduction of 
teaching on infective endocarditis and antibiotic prophylaxis into undergraduate 
dental and medical curricula. 
 
Finally 
Although subtle, this change makes NICE guidance less dogmatic and allows 
clinicians to use their clinical judgement and provide the care their patients want Ȃ it is therefore very welcome. However, it leaves 3 important information gaps 
for clinicians involved in its implementation. This paper attempts to provide 
practical advice for dentists (based on the ESC guidelines) while we await the 
response of professional or official organisations to more formally fill the gap.  
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